Pulmonary Medicine / 2014 / Article / Tab 1 / Research Article
Retrospective Observations on the Ability to Diagnose and Manage Patients with Asthma through the Use of Impulse Oscillometry: Comparison with Spirometry and Overview of the Literature Table 1 Patient Spirometry and IOS Baseline.
Asthma patient Age Inhaled steroid Before FEV1 Post bronchodilator FEV1 % Chg Before AX Post bronchodilator AX % Chg Before R5 Post bronchodilator R5 % Chg Before R15 After R15 % Chg 1 41 Mometasone furoate 4.03 3.27 −19.00% 11.98 6.94 −42.10% 4.12 3.41 −17.30% 3.2 2.62 −18.30% 2 41 Fluticasone/salmeterol 4.16 4.12 −1.00% 10.37 6.36 −38.70% 4.03 3.86 −4.10% 2.83 2.77 −1.90% 3 45 Ciclesonide 3.6 2.94 −18.30% 4.44 5.24 17.90% 2.78 2.47 −10.90% 1.99 1.64 −17.50% 4 78 Mometasone furoate 2.26 2.74 21.60% 7.05 3.13 −55.50% 2.79 72.2 −15.90% 1.87 1.74 −7.20% 5 65 Budesonide/formoterol 1.5 1.79 19.10% 6.22 3.81 −38.70% 3.02 2.36 −21.80% 2.07 1.69 −18.20% 6 71 Beclomethasone dipropionate 1.37 1.28 −6.40% 32.15 24.39 −24.20% 6.18 5.25 −15.00% 3.74 3.71 −1.10% 7 44 Budesonide/formoterol 3.54 3.87 9.20% 11.82 2.49 −78.90% 4.55 3.21 −29.40% 3.85 2.91 −24.40% 8 47 Mometasone furoate 2.18 2.65 21.40% 7.74 5.59 −27.80% 3.62 3.48 −3.90% 2.53 2.62 3.70% 9 59 Ciclesonide 2.26 2.26 0.20% 8.71 6.75 −22.50% 3.71 3.24 −12.60% 2.49 2.21 −11.00% 10 35 Mometasone furoate 3.81 4.01 5.10% 7.4 6.5 −12.20% 3.01 3.56 18.20% 2.32 2.46 5.80% 11 60 Mometasone furoate 1.91 1.95 2.40% 23.86 19.05 −20.20% 6.47 5.29 −18.20% 3.98 3.31 −16.80% 12 31 Ciclesonide 4.13 4.13 −0.10% 2.28 1.04 −54.60% 2.72 2.43 −10.60% 2.29 2.29 −0.30% 13 51 Budesonide/formoterol 1.97 1.85 −6.00% 14.32 11.78 −17.70% 4.64 4.14 −11.00% 2.72 2.64 −2.80% 14 29 Mometasone furoate 3.93 4.18 5.30% 4.08 2.99 −26.70% 2.39 2.45 2.60% 1.92 1.8 −6.20% 15* 36 Mometasone furoate 3.61 3.89 7.80% 6.32 4.59 −27.30% 3.14 3.37 7.20% 2.76 2.94 6.70% 16 51 Budesonide 2.32 2.36 1.90% 7.43 5.63 −24.30% 2.79 3.11 11.50% 2.29 2.39 4.20% 17 50 Budesonide 3.11 3.25 4.70% 3.05 1.88 −38.20% 3.63 3.05 −15.90% 3.19 2.67 −16.30% 18 83 Fluticasone/salmeterol 2.49 2.21 −11.30% 6.36 9.18 44.30% 2.25 2.66 18.20% 1.84 1.8 −2.20% 19 57 Fluticasone/salmeterol 1.91 1.94 1.50% 22.44 20.31 −9.50% 4.3 4.18 −2.80% 2.75 2.67 −3.20% 20 37 Mometasone furoate 3.78 3.51 −7.10% 7.41 5.34 −28.00% 3.69 3.37 −8.60% 2.85 2.66 −6.90% 21 51 Ciclesonide 2.64 2.73 3.50% 9.4 7.54 −19.80% 4.01 3.31 −17.40% 2.88 2.48 −14.00% 22 24 Mometasone furoate 3.95 3.72 −5.70% 5.55 2.95 −46.80% 2.92 2.41 −17.40% 2.17 1.91 −12.00% 23 35 Budesonide/formoterol 2.38 2.86 20.50% 6.23 2.35 −62.20% 3.56 2.18 −38.70% 3.15 1.95 −38.20% 24 61 Budesonide/formoterol 2.48 2.56 3.20% 10.87 9.11 −16.20% 3.86 3.58 −7.30% 2.62 2.43 −7.30% 25 33 Mometasone furoate 2.74 2.73 −0.30% 9.86 9.56 −3.00% 3.66 4.09 11.80% 2.41 2.49 3.30% 26 49 Mometasone furoate 2.96 2.99 1.20% 7.66 6.06 −20.80% 3.97 3.86 −2.90% 3.06 3.05 −0.10% 27 65 Fluticasone/salmeterol 1.73 1.87 7.90% 4.78 5.55 16.10% 2.97 3.99 34.20% 2.4 3.66 52.50% 28 31 Mometasone furoate 2.56 2.19 −14.40% 5.37 2.96 −44.90% 3.73 3.38 −9.40% 2.64 2.8 6.00% 29 74 Mometasone furoate 1.6 1.67 4.90% 14.06 11.15 −20.70% 3.65 3.23 −11.50% 2.54 2.38 −6.30% 30 54 Ciclesonide 2.36 2.7 14.10% 5.23 2.08 −60.20% 2.6 2.18 −15.90% 2.05 1.87 −8.80% 31 54 Ciclesonide 2.53 2.54 0.40% 9.46 7.24 −23.50% 2.85 2.76 −3.10% 1.94 1.87 −3.60% 32 53 Ciclesonide 3.01 3.1 3.10% 20.7 18.9 −8.70% 4.83 4.97 2.80% 3.28 3.17 −3.30% 33 60 Budesonide/formoterol 1.63 1.7 4.40% 15.32 4.46 −70.90% 4.91 3.83 −22.20% 3.9 3.34 −14.20% 34 80 Mometasone furoate 2.3 2.54 10.10% 19.97 5.98 −70.00% 4.2 2.97 −29.40% 2.85 2.29 −19.80% 35 65 Fluticasone/salmeterol 1.69 1.8 6.70% 16.32 7.38 −54.80% 4.45 3.41 −23.20% 2.95 2.47 −16.30% 36 71 Mometasone furoate 1.56 1.67 6.70% 5.68 7.31 28.80% 2.11 3.08 46.20% 1.7 2.42 42.20% 37 23 Fluticasone/salmeterol 3.36 3.74 11.30% 21.19 5.63 −73.40% 4.39 2.85 −35.00% 2.86 2.38 −16.90% 38 63 Beclomethasone dipropionate 2.73 2.77 1.60% 6.05 4.69 −22.40% 3.07 2.83 −8.00% 2.33 2.22 −4.90% 39 52 Budesonide 1.81 1.97 8.60% 15.74 6.46 −58.90% 3.8 2.66 −30.00% 2.4 1.72 28.20%
denotes patient that is referenced in Figure 1 .